Coordinates: 12°51′58″N 74°51′43″E / 12.86611°N 74.86194°E / 12.86611; 74.86194Father Muller Medical College, (ಫಾದರ್ ಮುಲ್ಲರ್ ಮೆಡಿಕಲ್ ಕಾಲೇಜು) located about a kilometre from the National Highway-66 (the Mumbai-Mangalore highway) at Kankanady in Mangalore, is a religious minority educational institution forming a part of the Father Muller Charitable Institutions (FMCI).
The present study describes the computational design and in silico evaluation of a multi-strain dengue antigen candidate intended for potential application in diagnostic platforms and as a vaccine-related component. Sixteen B-cell epitopes were initially retrieved from the Immune Epitope Database (IEDB) and screened for antigenicity and toxicity, leading to the selection of eight epitopes. These epitopes were joined using KK linkers and optimized to generate a 17 kDa construct exhibiting favourable stability and hydrophilicity. Immunogenicity predictions suggested a robust in silico antibody response. Molecular docking with the dengue-specific monoclonal antibody 1A1D-2 yielded a stable antigen–antibody complex, and molecular dynamics simulations demonstrated enhanced stability of the antigen in the complexed state compared to the unbound form. These observations were further supported by MM/PBSA binding free-energy calculations. Collectively, these findings support the designed construct as a computationally validated multi-strain dengue antigen candidate. However, extensive experimental validation will be required to establish its suitability for diagnostic or vaccine-related applications, which will be addressed in future studies. Reference sequences of all four dengue virus serotypes were retrieved from NCBI. Dengue-specific B-cell epitopes were identified from IEDB. Immunogenicity was simulated using C-IMMSIM. Secondary and tertiary structures were predicted with PSIPRED and Phyre2. Protein–protein docking with the monoclonal antibody Fab 1A1D-2 (PDB 2R29) was performed on the HDOCK server. Molecular dynamics simulations totalling 1200 ns; four 300 ns replicate simulations of antigen–antibody complex were carried out in GROMACS 2023.8 using the CHARMM27 force field, TIP3P water model, and Particle Mesh Ewald electrostatics. Analyses were performed using GROMACS utilities, and MM/PBSA binding free energy calculations were conducted with gmx_MMPBSA to evaluate antigen–antibody complex stability.
A BSTRACT Background: In locally advanced Laryngeal and hypopharyngeal cancer, definitive chemoradiation therapy has become the preferred treatment owing to its organ preservation advantages. It is recognized for inducing considerable short- and long-term toxicity when administered at extreme dosages. Research indicates that patients undergoing radiation therapy (RT) in conjunction with chemotherapy experienced more severe toxicity, such as mucositis. Associated radiation exposure to the buccal mucosa during treatment with radiation for carcinomas of the larynx and pharynx leads to acute radiation-induced oral mucositis (RIOM). Objectives: To assess the dose received by buccal mucosa and oral mucositis in patients receiving combined chemoradiation for treatment of laryngeal and hypopharyngeal cancers with volumetric modulated arc therapy (VMAT). Materials and Methods: Forty-five patients with histologically proven squamous cell carcinoma of the larynx and hypopharyx cancer, who received chemoradiation therapy by VMAT were analyzed. The total prescribed dose was 70 Gy delivered in 2 Gy daily fractions with concurrent weekly injection cisplatin (35 mg/m 2 )/carboplatin area under the curve 2 (AUC 2). Dosimetric parameters of right and left buccal mucosa (V 15 Gy and V 30 Gy) were recorded and correlated with grades of RIOM as per CTCAE v5.0. Results: Mucositis and weight loss were assessed from week 1 to 7. Grade 2 and 3 mucositis was observed in 66.7% ( n = 30) and 4.4% ( n = 2). None of the patients developed Grade 4 or more. Weight loss of Grade 2 and 3 was observed in 42.2% ( n = 19) and 57.8 ( n = 26). Increase in dose to buccal mucosa showed a significant ( P < 0.001) with oral mucositis. Conclusion: The incidence of various RIOM was evaluated in this study as a predictor of the dosage administered to the buccal mucosa in patients with laryngeal and hypopharyngeal cancer. In HNCs receiving radical chemoradiation therapy, our data showed a correlation between buccal mucosa V15Gy and V30Gy and oral mucosal toxicity.
Background Acne vulgaris is a common skin condition that typically begins in adolescence but can often persist in adulthood, contributing to significant physical and psychosocial burden. Despite the availability of multiple treatment options, challenges such as poor adherence, treatment-related side effects, and post-inflammatory hyperpigmentation remain common in clinical practice. Dermocosmetics are increasingly used in acne management, either alone in mild cases or as adjuncts to medical therapy.Objectives To assess acne prevalence, treatment practices, and key management challenges, along with the role of dermocosmetics, based on expert consensus from India.Methods A panel of 10 dermatologists participated in a modified Delphi process comprising a pre-meeting survey followed by a structured advisory board discussion, capturing clinical practice patterns, treatment approaches, and perspectives on dermocosmetic use in acne management.Results Experts reported treating a high number of acne patients, primarily adolescents, with a higher proportion of females. Hyperpigmentation and scarring were common sequelae of acne, while treatment adherence and antibiotic resistance, particularly to erythromycin and azithromycin, were noted as key challenges. Procedural interventions, including chemical peels, lasers, and comedone extraction, were increasingly used in early acne management, especially in patients prone to post-inflammatory hyperpigmentation and relapse. Low-dose isotretinoin and hormonal therapies were commonly used in acne management, while dermocosmetics were utilized as monotherapy in mild cases and as maintenance therapy following treatment in more severe cases. Lifestyle factors such as high glycaemic diets, whey protein, multivitamins, and steroid-like drugs were identified as potential contributors to acne exacerbation.Limitations Findings are based on a small expert panel convened with industry support and reflect clinical opinion rather than primary patient data.Conclusion Procedural interventions are becoming more popular, thereby providing an opportunity to incorporate dermocosmetics into acne treatment regimens.